Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 19 July 2024

Time: 19:28

Birmingham NeuroEndocrine Tumour Centre

A European NeuroEndocrine Tumour Society (ENETS) Certified Centre of Excellence

The Birmingham NeuroEndocrine Tumour (NET) Centre is based at Queen Elizabeth Hospital Birmingham (QEHB). It is an ENETS-certified Centre of Excellence that has been providing a specialist service to patients for 30 years.

We are providing the latest cancer therapies to patients, including:

  • medical treatments for carcinoid syndrome
  • highly specialised cancer surgery
  • carcinoid heart disease surgery
  • nuclear medicine “magic bullet” treatments such as Yttrium or Lutetium radionuclide therapy (called PRRT)
  • targeted chemotherapies such as everolimus and sunitinib
  • complex radiological interventions including radiofrequency ablation and trans-arterial embolisation
  • urology treatments
  • dietary advice
  • psychological and social support

We aim to provide a patient-focused service that is also convenient to access. To this end all NET patients are managed according to individualised treatment plans. In addition, both medical and surgical specialists are present in the joint NET clinic, enabling us to deal with most of our patients’ issues in one place.

We are leading the way in empowering patients to get the best from the health service. QEHB patients can have access to their records online through myhealth@QEHB (see link below). Patients are also able to keep an electronic symptoms diary. We are developing this system further to allow each patient to have their personalised healthcare plan.

QEHB and University of Birmingham are developing the Institute of Translational Medicine and Centre for Rare Diseases in order to accelerate improvements in patient survival. These developments offer tremendous opportunities for patients and doctors to work together to greatly improve patient experience and outcomes.

The Birmingham NET Centre has been generously supported by neuroendocrine tumour patients and Queen Elizabeth Hospital Birmingham Charity (see link below).


External websites will open in a new browser window.

University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.